WXXWY News and Press, Wuxi Biologics Cayman Inc ADR From 03/26/20

Wuxi Biologics ADR ( OTCPK:WXXWY ): FY Non-GAAP EPS of RMB0.91; GAAP EPS of RMB0.76. More news on: Wuxi Biologics (Cayman) Inc ADR, WuXi Biologics (Cayman) Inc., Earnings news and commentary, , Read more ...

CHF Solutions (NASDAQ: CHFS )  announced the use of its Aquadex ultrafiltration therapy to treat volume overload in COVID-19 patients. Shares up  35%  premarket. More news on: CHF Solutions, Inc., Endonovo Therapeutics, Inc., Twist Bioscience Corporation, Healthcare stocks ...

DUNDALK, Ireland , March 11, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that it has completed the weather-tig...

Vir Biotechnology ( VIR +27.6% ) jumps to all-time highs after announcing a development and manufacturing collaboration with WuXi Biologics ( OTCPK:WXXWY ) to advance and produce antibodies for a potential coronavirus treatment . More news on: Vir Biotechnology, Inc., Wuxi Biologics (Ca...

SAN FRANCISCO and SHANGHAI , Feb. 25, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and Vir Biotechnology, Inc. ("Vir") ...

SHANGHAI , Feb. 24, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, congratulates its strategic partner Immutep, a biot...

SHANGHAI , Feb. 18, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that WuXi Vaccines, its joint venture with Sha...

SHANGHAI , Feb. 18, 2020 /PRNewswire/ -- WuXi Vaccines, a new vaccine Contract Development and Manufacturing Organization (CDMO) established between WuXi Biologics (stock code: 2269.HK) and Shanghai Hile Bio-technology (stock code: 603718.SH) announced that it has entered into a strategic...

SHANGHAI , Feb. 12, 2020 /PRNewswire/ -- WuXi Biologics is closely monitoring the coronavirus outbreak. Our management team is working vigilantly to execute our Business Continuity Plan to mitigate any potential risk. All three operating sites in China , namely Wuxi, Shanghai and ...

SHANGHAI , Jan. 29, 2020 /PRNewswire/ -- The coronavirus outbreak is having a potentially significant social and economic impact in China . WuXi Biologics is closely monitoring the coronavirus outbreak and is complying with guidance from the relevant authorities. Our management team is w...